A Non-interventional Multicenter Study of First-line Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
Phase of Trial: Phase IV
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 10 Aug 2017 Status changed from active, no longer recruiting to completed.
- 04 May 2016 Planned End Date changed from 1 Feb 2016 to 1 Oct 2016.
- 04 May 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Oct 2016.